Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.
Jennifer Doudna
BEGIN Berkeley Gateway to Innovation portal to the UC Berkeley entrepreneurship community
Follow @BerkeleyIPIRA
Accessibility | Nondiscrimination | Privacy